In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are used in the collection, preparation, and examination of specimens taken from the human body. This includes Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers, Oncology and Reproductive Health Diagnostics. A Cardiac Marker Test is a biomarker test used to diagnose a cardiac disease event or predict the likelihood of cardiac disease through the measurement of Troponin, Brain Natriuretic Peptide, Creatine Kinase Myocardial Band (CK-MB) , and other target molecules. GlobalData uses proprietary data and analytics to provide a comprehensive report on the cardiac marker tests devices market, including market shares of different players within Italy. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the cardiac marker tests market in Italy was Abbott Laboratories followed by F. Hoffmann-La Roche, Siemens Healthineers, Danaher, Quidelortho and bioMerieux.
Cardiac Marker Tests are categorized into lab-based biomarker and point of care biomarker tests. Laboratory Tests: Any tests that require transporting of patient samples to a laboratory, including those with rapid turnaround times, are defined as laboratory or lab-based tests. For this Cardiac Marker Tests, lab-based tests include laboratory troponin tests, laboratory BNP tests, and CK-MB laboratory tests. Point Of Care Tests: Point of Care Testing (POC) is defined as medical diagnostic testing performed outside the clinical laboratory in close proximity to where the patient is receiving care. POC is typically performed by non-laboratory personnel and the results are used for clinical decision making. These devices range from manual methods to automated analyzers and are often handheld or compact portable analyzers. For this Cardiac Marker Tests, POC tests include POC Troponin Tests, POC BNP tests, and other POC Tests.
The value of the cardiac marker tests devices market within Italy was expected to be over $40m in 2023.
For the latest complete market share analysis of cardiac marker tests device market in Italy, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.